Legal & General Group Plc Raises Stock Position in Option Care Health, Inc. $OPCH

Legal & General Group Plc increased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 0.7% during the second quarter, HoldingsChannel.com reports. The fund owned 283,158 shares of the company’s stock after acquiring an additional 2,092 shares during the period. Legal & General Group Plc’s holdings in Option Care Health were worth $9,197,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Avantax Advisory Services Inc. bought a new position in shares of Option Care Health in the first quarter worth $494,000. Natixis Advisors LLC grew its position in Option Care Health by 33.8% during the first quarter. Natixis Advisors LLC now owns 50,654 shares of the company’s stock worth $1,770,000 after buying an additional 12,802 shares in the last quarter. US Bancorp DE increased its stake in Option Care Health by 5.0% in the 1st quarter. US Bancorp DE now owns 8,199 shares of the company’s stock worth $287,000 after acquiring an additional 393 shares during the last quarter. Geneva Capital Management LLC increased its stake in Option Care Health by 5.1% in the 1st quarter. Geneva Capital Management LLC now owns 781,625 shares of the company’s stock worth $27,318,000 after acquiring an additional 38,105 shares during the last quarter. Finally, Wealthspire Advisors LLC purchased a new stake in shares of Option Care Health in the 1st quarter valued at about $206,000. 98.05% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

OPCH has been the subject of several recent analyst reports. JMP Securities set a $36.00 price objective on Option Care Health in a report on Friday, October 31st. Morgan Stanley began coverage on shares of Option Care Health in a research note on Friday, October 17th. They issued an “overweight” rating and a $35.00 price target for the company. TD Cowen lowered their price objective on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a research report on Monday, November 3rd. Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a report on Friday, October 31st. Finally, Citigroup reissued an “outperform” rating on shares of Option Care Health in a research note on Friday, October 31st. Nine research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $35.67.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were bought at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the transaction, the director directly owned 413,390 shares in the company, valued at $10,739,872.20. This trade represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Norman L. Wright purchased 3,411 shares of the stock in a transaction on Tuesday, September 9th. The stock was acquired at an average cost of $29.31 per share, with a total value of $99,976.41. Following the completion of the purchase, the director directly owned 15,501 shares of the company’s stock, valued at $454,334.31. The trade was a 28.21% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.64% of the stock is owned by company insiders.

Option Care Health Trading Down 0.5%

OPCH stock opened at $30.94 on Tuesday. The company has a market capitalization of $4.91 billion, a PE ratio of 24.75, a price-to-earnings-growth ratio of 1.74 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. Option Care Health, Inc. has a one year low of $22.29 and a one year high of $35.53. The company’s 50 day moving average price is $28.03 and its two-hundred day moving average price is $29.38.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.